Glp-1 advertising Trends & Statistics
EMARKETER offers market research, trends and statistics for a variety of topics and industries. Here you will find a collection of reports, articles and other resources for Glp-1 advertising
Novo Nordisk sues Eli Lilly over ‘misleading’ drug ads as GLP-1 marketing rivalry escalates
Article
Jul 21, 2026
Novo's GLP-1 ad lawsuit against Lilly could redefine the standards for comparative drug advertising in a market projected to reach $200 billion.
Noom takes GLP-1 advertising beyond prescription access to lasting weight loss
Article
Jul 20, 2026
The next phase of GLP-1 marketing competition may hinge on whether brands convince consumers to stay on treatment or build habits that last after stopping them.
Pharma linear TV ad decline in H1 driven by steep GLP-1 spending cuts
Article
Jul 16, 2026
The decline mostly reflects pullbacks in diabetes and blood disorder advertising, not a broad retreat from linear TV advertising.
Powerful data and analysis on nearly every digital topic.
Become a ClientWant more marketing insights?
Sign up for EMARKETER Daily, our free newsletter.
By clicking "Sign Up", you agree to receive emails from EMARKETER (e.g. FYIs, partner content, webinars, and other offers) and accept our Terms of Service and Privacy Policy. You can opt-out at any time.
Thanks for signing up for our newsletter!
You can read recent articles from EMARKETER here.Already have a subscription?Sign In
Access All Charts and Data
- Learn about what technologies are transforming your industry
- Gain exclusive perspectives from top industry leaders
- Access thousands of data sets and forecasts via our iconic charts